New drug MT-304 targets Hard-to-Treat HER2 cancers in early trial
NCT ID NCT07334119
First seen Jan 12, 2026 · Last updated May 04, 2026 · Updated 13 times
Summary
This early-phase study tests a new drug called MT-304, given alone or with another drug (nivolumab), in adults with advanced HER2-expressing solid tumors. The main goals are to check safety and find the best dose. About 60 participants will receive the treatment every two to four weeks until their disease gets worse or side effects become too severe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2 EXPRESSING SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cabrini Health
RECRUITINGMelbourne, Victoria, 3144, Australia
Contact Phone: •••-•••-••••
Contact
-
Calvary Mater Newcastle
RECRUITINGWaratah, New South Wales, 2298, Australia
Contact
Contact Phone: •••-•••-••••
-
Cancer Research SA Pty Ltd
RECRUITINGAdelaide, South Australia, 5000, Australia
Contact Phone: •••-•••-••••
Contact
-
Icon Cancer Centre South Brisbane
RECRUITINGSouth Brisbane, Queensland, 4101, Australia
Contact Phone: •••-•••-••••
Contact
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, 6009, Australia
Contact Phone: •••-•••-••••
Contact
-
Scientia Clinical Research Ltd
RECRUITINGRandwick, New South Wales, 2031, Australia
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.